Postdoctoral researcher at the Cellular and Molecular Mechanobiology Research Group.
Ref: PR-PR //Deadline: 15/12/2023
Ref: PR-PR //Deadline: 15/12/2023
IBEC and Vitala, a spin-off founded by IBEC researchers, are set to participate in three public-private partnership projects, with a combined investment nearing €4 million. These initiatives, backed by the Spanish Ministry of Science and Innovation and the State Research Agency, aim to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge technological approaches, these endeavors aspire to make a positive impact on the fields of medicine and biomedical research.
Ref: RA_GB // Deadline 12/12/2023
We are excited to announce an upcoming event that promises to be both insightful and empowering – the “She Leads” Round Table Discussion. This event will bring together distinguished participants … Read more
NANOMEDSPAIN organizes together with the Leitat technology center a conference on the call for Public-Private Collaboration Projects that will open at the beginning of 2024. Mª Estefanía Freitas, Deputy Head … Read more
3D bioengineered liver for the study of acute and chronic hepatic damage Ainhoa Ferret, Biosensors for bioengineering group The liver, a vital organ, faces acute and chronic insults that disrupt … Read more
For the sixth consecutive year, IBEC has successfully hosted its ‘Mad for Bioengineering’ course with the support of the Catalunya La Pedrera Foundation. Geared towards 1st-year high school students interested in STEM careers, the program provides a unique immersion in the field of bioengineering, addressing health issues from a multidisciplinary perspective. The closing ceremony, attended by students and their families, featured presentations of final projects and the awarding of diplomas.
Integrating phenotypic targeting in physiologically-based pharmacokinetics modeling. Zhendong Xie, Molecular Bionics group Selective drugging, also known as the “magic bullet,” is the concept that drugs can target specific molecules, cells, … Read more
The NanoBio&Med 2023 International Conference, held last week at the Barcelona Science Park (PCB) from November 21 to 23, has marked a milestone by presenting the latest developments in the … Read more
The researcher at the Institute for Bioengineering of Catalonia has been awarded an ERC Consolidator Grant. This prestigious European funding supports excellent scientists and scholars who are consolidating their independent research teams to pursue their most promising scientific ideas. The €2 million grant over 5 years will allow Bolognesi and her team to develop a new method for identifying mutations that lead to the formation of amyloids—aggregates of proteins that contribute to a variety of diseases, including Alzheimer’s and Parkinson’s.